Jakes A D, Roy A, Veerasamy M, Bhandari S
Hull York Medical School, University of Hull, Hull, United Kingdom.
Transplant Proc. 2013 Mar;45(2):842-4. doi: 10.1016/j.transproceed.2012.11.003.
Diarrhea is considered to be a common side effect after renal transplantation, due to a number of infective or drug-related causes. Over the past decade the etiology has perhaps changed with the evolution of immunosuppression. In an attempt to minimize early acute rejection and potential steroid use, the recent introduction of mycophenolic acid-based therapies has increased the incidence of diarrheal symptoms. Histologic and macroscopic appearance of mycophenolate-induced colitis is not well documented.
Three patients with immunosuppression-induced colitis had received deceased-donor renal transplantations and presented with diarrhea and/or abdominal pain. All patients made a full recovery after decreasing the dose or withdrawing mycophenolate mofetil or myfortic with corticosteroid-free regimens.
Patients with immunosuppression-induced colitis require prompt intervention by dose reduction or withdrawal. Both myocophenolate mofetil and myfortic can induce a Crohn's-like colitis even after a long period of exposure. The symptoms may require 6 months to resolve, suggesting that surgery should be considered only as a last resort after a significant period off therapy.
腹泻被认为是肾移植后常见的副作用,由多种感染性或药物相关原因引起。在过去十年中,随着免疫抑制疗法的发展,病因可能发生了变化。为了尽量减少早期急性排斥反应和潜在的类固醇使用,最近引入的基于霉酚酸的疗法增加了腹泻症状的发生率。霉酚酸酯诱导的结肠炎的组织学和宏观表现尚无充分记录。
三名免疫抑制性结肠炎患者接受了尸体供肾移植,出现腹泻和/或腹痛。所有患者在减少剂量或停用霉酚酸酯或麦考酚钠并采用无皮质类固醇方案后均完全康复。
免疫抑制性结肠炎患者需要通过减少剂量或停药进行及时干预。霉酚酸酯和麦考酚钠即使在长期使用后也可诱发克罗恩样结肠炎。症状可能需要6个月才能缓解,这表明仅在停止治疗相当一段时间后作为最后手段才应考虑手术。